Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation

NCT05711667 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT05711667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05711667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Recruiting
Start date
July 11, 2024
Completion date
June 30, 2029
Enrollment
105 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm